Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > August 2008

« Previous month Next month »

Applied Biosystems removes the bias from gene expression analysis

29-Aug-2008 -  Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.

Oxford Diffraction goes ‘SuperNova’

29-Aug-2008 -  Oxford Diffraction has launched a new dual wavelength X-ray diffractometer that promises to determine the structure of molecules in even the most challenging of crystal samples.

Controlling the quality of protein datasets

29-Aug-2008 -  Hungarian researchers have developed a new bioinformatics tool that can identify and correct abnormal, incorrect and mispredicted protein annotations in public databases.

New research takes the bite out of the stem cell debate

29-Aug-2008 -  Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.

Boehringer hooks up with Chinese API firm

28-Aug-2008 - Boehringer Ingelheim has formed a strategic production alliance with Chinese manufacturer Hisoar, significantly expanding its worldwide API network.

Codexis and Arch prepare for generic Lipitor market

28-Aug-2008 - Codexis and Arch Pharmalabs’ expanded supply and development deal will see the latter produce APIs used in the manufacture of atorvastatin, principal component of Pfizer’s cholesterol buster Lipitor.

Israeli court rules against “disingenuous” Taro

28-Aug-2008 - The Tel-Aviv District Court has found in favour of Sun Pharmaceuticals in its long running struggle to acquire Israeli drug and pharmaceutical ingredient maker Taro Pharmaceutical Industries.

Exclusive interview

Equateq bullish about lipid API market

27-Aug-2008 - A facility operated by fatty acid specialist Equateq on the island of Lewis in Scotland has met with UK good manufacturing practice (GMP) standards for the production of lipid-based APIs...

Pharma manufacturing: people on the move

27-Aug-2008 - presents its latest round-up of personnel changes in the pharmaceutical sector.  

FDA warns Sandoz on unvalidated manufacturing

27-Aug-2008 -  The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson,...

Second Daytrana recall as liner problems continue

26-Aug-2008 -  Shire and Noven have voluntarily withdrawn batches of the ADHD drug Daytrana for the second time in 12 months due to ongoing problems with the product’s release liner. 

Daewoong to sell Eurand’s cyclobenzaprine ER

26-Aug-2008 -  Drug delivery specialist Eurand is to begin supplying its extended release formulation of cyclobenzaprine HCl to South Korea’s Daewoong Pharmaceuticals.  

Pharma manufacturing products: news in brief

26-Aug-2008 -’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from innovatis, Stäubli, GE and Sterilin.

Funding imminent for versatile drug delivery tech

26-Aug-2008 - NanoBio is believed to be on the verge of securing funding to continue developing its NanoStat drug delivery platform.

Abbott and Pfizer shed jobs as Gilead plans growth

25-Aug-2008 -’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.

FDA seizes drugs worth $74,000

25-Aug-2008 - The US Food and Drug Administration (FDA) has ordered the seizure of $74,000 worth of Xiadafil VIP tablets after SEI Pharmaceuticals refused to withdraw them from the market.

Drug delivery penetrates mucus barrier

25-Aug-2008 - Researchers claim to have developed a drug delivery system capable of passing through the mucus barrier, which had previously been impenetrable to therapeutics.

New well plate differentiates itself from the crowd

22-Aug-2008 - Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.

Agilent’s life science sales grow as profits drop

22-Aug-2008 - Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.

Probing the structure of membrane proteins

22-Aug-2008 - US researchers have developed a new technique that has enabled them to determine the structure of membrane proteins without having to first crystallise the samples.

Bruker ‘forces’ its way into the AFM market

22-Aug-2008 - Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.

New MRI platform makes PharmaSense

21-Aug-2008 -  OIMBL’s PharmaSense is a versatile MRI tool that allows drugmakers to assess tablet dynamics and potentially improve API delivery, according to company managing director Frank Trundle. 

Unraveling the stabilisation of proteins

21-Aug-2008 - Evaluating the sugars used to stabilise proteins will be faster, cheaper and more efficient thanks to new technology, claim researchers.

Crossing the BBB for treating Parkinson’s

21-Aug-2008 - US-based biotech ArmaGen Technologies has received funding from the Michael J Fox Foundation (MJFF) for the development of its drug delivery technology.

NJ and the shifting landscape of pharma employment

20-Aug-2008 - People employed in the pharmaceutical industry in New Jersey, USA fell by one per cent in 2007, according to a report by the HealthCare Institute of New Jersey (HINJ). 

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...